Completed OBSERVATIONAL NCT04796181

Heart Rate and Respiratory Rate Measurements by a Novel, Radar-based Device

Single Center, Single Blinded, Prospective Validation Study for the Accuracy and Safety Evaluation of Neteera 130H, a Novel, Radar-based Contact-free Device for Heart and Respiratory Rate Measurements

Sponsor: Neteera Technologies Ltd.

Conditions Chronic Conditions, Multiple Healthy Subjects

Interventions Neteera 130H

Updated 6 times since 2021 Last updated: Oct 4, 2022 Started: Feb 21, 2021 Primary completion: Mar 25, 2022 Completion: Jul 2, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chronic Conditions, Multiple and Healthy Subjects and is currently completed. Neteera Technologies Ltd. leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Nov 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Apr 2022 — Nov 2022 [monthly]

Recruiting

Status: Completed → Recruiting
Sep 2021 — Apr 2022 [monthly]

Completed

Status: Recruiting → Completed

▶ Show 1 earlier version

Apr 2021 — Sep 2021 [monthly]

Recruiting

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neteera Technologies Ltd.

Data source: Neteera Technologies Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel
• Millcreek, United States